With the tax perhaps unlikely to ever take effect, should companies still factor it into their benefits planning and strategies?
The 420-employer National Business Group on Health recommends public-policy changes relating to the proliferating category of specialty drugs.
A proposal to postpone the despised excise tax is an 11th-hour inclusion in the federal budget bill.
Companies and others are loudly decrying the impending excise tax on high-cost health plans — and for good reason.
Low-paid workers who now will be eligible for generous federal subsidies to buy health insurance next year may have grounds to sue their employers in 2015.
New regulations could make certain programs more costly and, worse, hinder them from achieving goals that can reduce a company’s health-care costs.
The Supreme Court opinion was not the one most of them wanted. But now finance chiefs need to work on compliance and make some tough decisions.
